14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Tuesday, 7th May 2024 ACOR stock ended at $0.661. During the day the stock fluctuated 0% from a day low at $0.661 to a day high of $0.661.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Acorda Therapeutics prices

Date Open High Low Close Volume
Sep 13, 2016 $24.87 $24.87 $24.87 $24.87 260 900
Sep 12, 2016 $24.94 $24.94 $24.94 $24.94 326 400
Sep 09, 2016 $23.75 $23.75 $23.75 $23.75 586 200
Sep 08, 2016 $24.88 $24.88 $24.88 $24.88 552 500
Sep 07, 2016 $24.49 $24.49 $24.49 $24.49 551 200
Sep 06, 2016 $24.45 $24.45 $24.45 $24.45 222 600
Sep 02, 2016 $24.27 $24.27 $24.27 $24.27 248 500
Sep 01, 2016 $24.34 $24.34 $24.34 $24.34 330 100
Aug 31, 2016 $24.08 $24.08 $24.08 $24.08 457 400
Aug 30, 2016 $24.53 $24.53 $24.53 $24.53 332 400
Aug 29, 2016 $24.53 $24.53 $24.53 $24.53 311 100
Aug 26, 2016 $24.30 $24.30 $24.30 $24.30 409 800
Aug 25, 2016 $24.48 $24.48 $24.48 $24.48 429 700
Aug 24, 2016 $24.29 $24.29 $24.29 $24.29 423 300
Aug 23, 2016 $25.62 $25.62 $25.62 $25.62 424 700
Aug 22, 2016 $25.94 $25.94 $25.94 $25.94 720 200
Aug 19, 2016 $24.85 $24.85 $24.85 $24.85 516 700
Aug 18, 2016 $25.00 $25.00 $25.00 $25.00 471 300
Aug 17, 2016 $24.19 $24.19 $24.19 $24.19 465 000
Aug 16, 2016 $24.05 $24.05 $24.05 $24.05 383 500
Aug 15, 2016 $24.26 $24.26 $24.26 $24.26 454 900
Aug 12, 2016 $24.22 $24.22 $24.22 $24.22 338 300
Aug 11, 2016 $24.02 $24.02 $24.02 $24.02 387 700
Aug 10, 2016 $23.75 $23.75 $23.75 $23.75 480 200
Aug 09, 2016 $23.99 $23.99 $23.99 $23.99 566 700
Click to get the best stock tips daily for free!

About Acorda Therapeutics

Acorda Therapeutics Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also markets Ampyra as Fampyra in Europe, Asia, and the Americas. In addition, the company develops ARCUS p... ACOR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT